Benzinga | Nov 24, 2021 08:21AM EST

Morgan Stanley Maintains Overweight on Medtronic, Lowers Price Target to $145

Morgan Stanley analyst Cecilia Furlong maintains Medtronic (NYSE:MDT) with a Overweight and lowers the price target from $154 to $145.